Lupin informs about investor presentation

07 Nov 2019 Evaluate

Lupin has informed that pursuant to Regulation 30(2) read with Schedule Ill Part A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it has enclosed is a copy of the Q2 FY2020 Investor Presentation.

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

1617.85 19.65 (1.23%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.